Democratic senator urges Trump not to resume nuclear weapons tests

The White House said President Trump has directed the Pentagon to immediately restart the process for explosive nuclear weapons testing after a 33-year moratorium, citing other countries’ testing programs. Senator Ed Markey urged the president not to resume tests, requested evidence by Dec. 15 that Russia or China are conducting secret nuclear tests, and warned a U.S. test could trigger larger Russian and Chinese tests; Moscow has ordered officials to draft proposals for potential tests. The announcement increases geopolitical tail risk and could prompt safe-haven flows and sector-specific moves (notably defense) if the situation escalates.

Analysis

Market structure: The immediate beneficiaries are large defense primes (Lockheed LMT, Northrop NOC, Raytheon RTX) and niche nuclear services (BWXT) as rhetoric raises the probability of higher procurement and modernization budgets; commodities (gold, oil) trade up as safe havens and risk premia rise. Losses concentrate in cyclical/high-beta tech and travel/airlines as risk-off hits discretionary spend and equity beta; server/enterprise names (SMCI) are exposed to capex delays even if structurally strong. Cross-asset mechanics: expect a 1–3 week flight-to-quality (T-bill/TLT bid, 5–10bp drop in 2–10y yields), USD strength, +3–8% gold move on sharp escalations, and oil spikes if supply disruption rhetoric intensifies.

Risk assessment: Tail risk includes an actual explosive test or coordinated escalation that triggers sanctions, causing >$15/bbl oil shocks and equity drawdowns >10% in days; probability low but convex. Time horizons split: days–weeks = volatility and flows; 1–6 months = defense re-rating as appropriations and contract awards move; 6–24 months = revenues realize but face supply-chain bottlenecks (specialty metals, rad-hard semis). Hidden dependency: Congress funding and NNSA execution lag can delay cash flows; watch export controls and supplier concentration.

Trade implications: Direct plays—establish measured longs in LMT/NOC/RTX (see decisions) and a tactical GLD hedge for 0–3 months. Use 3–6 month call spreads on primes to capture re-rating while limiting premium; buy BWXT for niche nuclear services exposure on a 6–12 month view. Pair trade: long defense ETF ITA vs short high-beta enterprise hardware (SMCI) to express rotation; size to 1–3% notional and use 8–10% stops.

Contrarian angles: Consensus prices near-term risk-off but underestimates procurement-to-revenue lag and supply constraints that can make smaller suppliers scarce assets—this favors primes with integrated supply chains, not smaller contractors. Reaction could be overdone if December 15 evidence is inconclusive; that would create a 10–20% buying window in beaten-down cyclicals. Historical parallel: post-1999 rhetoric boosted defense budgets only after 12–18 months, so look for legislative funding signals before levering positions aggressively.

Key Decisions for Investors

• Establish a 2–3% portfolio long split between NOC (1–1.5%) and LMT (1–1.5%) within 2 weeks; target 15–25% upside over 3–6 months, set trailing stop-loss at -8% and scale out 50% at +12%.
• Initiate a 1–2% tactical hedge in GLD for the next 0–3 months (add if gold > $2,000 or VIX > 25); take profits if gold drops >7% from entry or after 3 months if volatility normalizes.
• Buy BWXT (BWXT) at 1% portfolio weight as a 6–12 month thematic on nuclear services; target +20% upside, stop-loss -12%; increase by +1% if U.S. or Russian policy actions are announced within 60 days.
• Deploy 0.5–1% notional in 3-month call spreads on NOC or RTX (buy ATM, sell +20% strike) to capture re-rating while capping premium; if implied vol rises >30% widen strikes to preserve ROI.
• Enter a pair trade: long ITA ETF 1–2% vs short SMCI 0.5–1% to express rotation into defense; reweight only after congressional funding signals or if by Dec 15 administration supplies credible evidence of foreign tests (increase long ITA by +1–2%).